Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Noxopharm Ltd. (AU:NOX)
ASX:NOX
NOX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.06 - AU$0.15
Previous CloseN/A
Volume154.85K
Average Volume (3M)124.94K
Market Cap
AU$25.42M
Enterprise ValueAU$16.97M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-1.68
Next Earnings
Aug 28, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding292,237,950
10 Day Avg. Volume58,792
30 Day Avg. Volume124,939
Standard Deviation0.31
R-Squared0.02
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Noxopharm Ltd. News
PremiumCompany Announcements
Noxopharm’s SOF-SKN™ Passes Key Safety Tests Ahead of Clinical Trials
PremiumCompany Announcements
Noxopharm Ltd. Issues Convertible Notes to Enhance Capital Structure
PremiumCompany Announcements
Noxopharm Issues New Unquoted Equity Securities
PremiumCompany Announcements
Noxopharm Ltd. Announces Issuance of New Unquoted Equity Securities
PremiumCompany Announcements
Noxopharm Faces Convertible Note Issuance Delay
PremiumCompany Announcements
Noxopharm Partners with CRO for HERACLES Trial
PremiumCompany Announcements
Noxopharm Achieves Key Approvals at Annual MeetingPremiumCompany Announcements
Noxopharm Unveils Strategic Advances and Market Prospects---
NOX FAQ
What was Noxopharm Ltd.’s price range in the past 12 months?
Noxopharm Ltd. lowest share price was AU$0.06 and its highest was AU$0.15 in the past 12 months.
What is Noxopharm Ltd.’s market cap?
Noxopharm Ltd.’s market cap is AU$25.42M.
When is Noxopharm Ltd.’s upcoming earnings report date?
Noxopharm Ltd.’s upcoming earnings report date is Aug 28, 2025 which is in 186 days.
How were Noxopharm Ltd.’s earnings last quarter?
Currently, no data Available
Is Noxopharm Ltd. overvalued?
According to Wall Street analysts Noxopharm Ltd.’s price is currently Overvalued.
Does Noxopharm Ltd. pay dividends?
Noxopharm Ltd. does not currently pay dividends.
What is Noxopharm Ltd.’s EPS estimate?
Noxopharm Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Noxopharm Ltd. have?
Noxopharm Ltd. has 292,237,950 shares outstanding.
What happened to Noxopharm Ltd.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Noxopharm Ltd.?
Currently, no hedge funds are holding shares in AU:NOX
---
Noxopharm Ltd. Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:NOX Sentiment 100%
Sector Average 70%
Sector Average 70%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
3.84%
12-Months-Change
Fundamentals
Return on Equity
-49.12%
Trailing 12-Months
Asset Growth
-33.02%
Trailing 12-Months
Company Description
Noxopharm Ltd.
Noxopharm Ltd is an Australian clinical-stage drug development company focused on treating cancer with Veyonda. It is engaged in the development in the field of both oncology and non-oncology in the pan-pacific region.
---
Technical Analysis
Biotron Limited
―
Opthea Limited
―
PYC Therapeutics Limited
―
Race Oncology Ltd.
―
Proteomics International Laboratories Ltd.
―
---